Method for reducing the incidence and prevalence of human papilloma virus (hpv) and for providing protection against sexually transmitted infections
AssigneesBarbara Sanders Esparza, Eleonora Sanders Esparza, Gina Patricia Sanders Esparza, Beatriz Sanders Esparza, Claudia Fabiola Sanders Esparza, Maria Fernanda Sanders Esparza, Olivia Andrea Sanders Esparza, Guillermo Sanders Castro, Eduardo Sanders Perez
InventorsGUILLERMO SANDERS ACEDO, ELEONORA SANDERS ESPARZA, BARBARA SANDERS ESPARZA
Life of this patent
Estimating the term…
Abstract
Methods comprising the insertion of a uterine cervical device into the lower part of the uterine cavity and endocervix for decreasing the incidence of the human papillomavirus in women, mainly types 16 and 18, thus preventing the development of uterine cervical cancer; for modifying the cervical microbiota; for increasing leukocytes and protecting against sexually transmitted infections in women.
Claims19
A method for reducing the incidence and prevalence of the human papillomavirus in women, mainly types 16 and 18, thus preventing the development of uterine cervical cancer in women, comprising the following steps:
- Providing a uterine cervical device comprising copper between approximately 380 mm2 to approximately 524 mm2, distributed on a T-shaped frame having a horizontal arm having a length of between about 17.8 millimeters and about 32.2 millimeters, said T-shaped frame having a vertical post extending from the horizontal arm, the vertical post having a length of between about 25.8 millimeters and about 36.2 millimeters and a diameter of about 1.7 millimeters, the horizontal arm having portions on opposite sides of the vertical post and a sphere affixed to the vertical post;
- said T-shaped frame made of inert plastic like polyethylene, propylene, polyester or silicone elastomer;
- Inserting said uterine cervical device in the lower part of the uterine cavity and endocervix;
- The device must be maintained in position up to approximately 5 years.
8) A method to modify the cervical microbiota of the women comprising the following steps:
- Providing a uterine cervical device comprising copper between approximately 380 mm2 to approximately 524 mm2, distributed on a T-shaped frame having a horizontal arm having a length of between about 17.8 millimeters and about 32.2 millimeters, said T-shaped frame having a vertical post extending from the horizontal arm, the vertical post having a length of between about 25.8 millimeters and about 36.2 millimeters and a diameter of about 1.7 millimeters, the horizontal arm having portions on opposite sides of the vertical post and a sphere affixed to the vertical post;
- said T-shaped frame made of inert plastic like polyethylene, propylene, polyester or silicone elastomer.
- Inserting said uterine cervical device inside of the female reproductive system, particularly in the lower part of the uterine cavity and endocervix where the human papillomavirus is incubated.
- The device must be maintained in position up to approximately 5 years.
12) A method to provide an increment in leukocytes in women comprising the following steps:
- Providing a uterine cervical device comprising copper between approximately 380 mm2 to approximately 524 mm2, distributed on a T-shaped frame having a horizontal arm having a length of between about 17.8 millimeters and about 32.2 millimeters, said T-shaped frame having a vertical post extending from the horizontal arm, the vertical post having a length of between about 25.8 millimeters and about 36.2 millimeters and a diameter of about 1.7 millimeters, the horizontal arm having portions on opposite sides of the vertical post and a sphere affixed to the vertical post;
- said T-shaped frame made of inert plastic like polyethylene, propylene, polyester or silicone elastomer;
- Inserting said uterine cervical device inside of the lower part of the uterine cavity and endocervix;
- The device must be maintained in position up to approximately 5 years.
Dependencies are inferred from the claim text.